Integer Holdings ROE 2010-2022 | ITGR
Current and historical return on equity (ROE) values for Integer Holdings (ITGR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Integer Holdings ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2022-09-30 |
$0.07B |
$1.36B |
5.30% |
| 2022-06-30 |
$0.08B |
$1.36B |
5.76% |
| 2022-03-31 |
$0.09B |
$1.36B |
6.41% |
| 2021-12-31 |
$0.10B |
$1.36B |
7.35% |
| 2021-09-30 |
$0.09B |
$1.33B |
6.77% |
| 2021-06-30 |
$0.10B |
$1.32B |
7.53% |
| 2021-03-31 |
$0.07B |
$1.28B |
5.40% |
| 2020-12-31 |
$0.08B |
$1.27B |
6.27% |
| 2020-09-30 |
$0.07B |
$1.23B |
6.09% |
| 2020-06-30 |
$0.07B |
$1.18B |
6.31% |
| 2020-03-31 |
$0.11B |
$1.16B |
9.30% |
| 2019-12-31 |
$0.10B |
$1.15B |
8.68% |
| 2019-09-30 |
$0.11B |
$1.13B |
10.24% |
| 2019-06-30 |
$0.20B |
$1.11B |
18.19% |
| 2019-03-31 |
$0.18B |
$1.08B |
17.79% |
| 2018-12-31 |
$0.17B |
$1.06B |
17.07% |
| 2018-09-30 |
$0.20B |
$1.04B |
20.80% |
| 2018-06-30 |
$0.10B |
$0.92B |
10.80% |
| 2018-03-31 |
$0.08B |
$0.92B |
9.24% |
| 2017-12-31 |
$0.07B |
$0.89B |
8.27% |
| 2017-09-30 |
$0.02B |
$0.82B |
2.73% |
| 2017-06-30 |
$0.02B |
$0.78B |
2.41% |
| 2017-03-31 |
$0.01B |
$0.74B |
1.91% |
| 2016-12-31 |
$0.01B |
$0.73B |
0.68% |
| 2016-09-30 |
$-0.03B |
$0.74B |
-3.68% |
| 2016-06-30 |
$-0.04B |
$0.72B |
-5.28% |
| 2016-03-31 |
$-0.03B |
$0.73B |
-4.04% |
| 2015-12-31 |
$-0.01B |
$0.85B |
-1.16% |
| 2015-09-30 |
$0.03B |
$0.65B |
4.90% |
| 2015-06-30 |
$0.05B |
$0.64B |
7.26% |
| 2015-03-31 |
$0.05B |
$0.63B |
7.93% |
| 2014-12-31 |
$0.06B |
$0.61B |
9.32% |
| 2014-09-30 |
$0.05B |
$0.60B |
8.91% |
| 2014-06-30 |
$0.05B |
$0.58B |
8.66% |
| 2014-03-31 |
$0.05B |
$0.57B |
8.61% |
| 2013-12-31 |
$0.04B |
$0.54B |
7.19% |
| 2013-09-30 |
$0.02B |
$0.52B |
4.21% |
| 2013-06-30 |
$0.00B |
$0.50B |
0.41% |
| 2013-03-31 |
$-0.00B |
$0.49B |
-0.83% |
| 2012-12-31 |
$-0.01B |
$0.48B |
-1.24% |
| 2012-09-30 |
$0.01B |
$0.48B |
1.25% |
| 2012-06-30 |
$0.02B |
$0.48B |
4.43% |
| 2012-03-31 |
$0.03B |
$0.48B |
5.54% |
| 2011-12-31 |
$0.03B |
$0.47B |
7.40% |
| 2011-09-30 |
$0.04B |
$0.46B |
9.34% |
| 2011-06-30 |
$0.04B |
$0.46B |
9.40% |
| 2011-03-31 |
$0.04B |
$0.44B |
9.57% |
| 2010-12-31 |
$0.03B |
$0.43B |
8.43% |
| 2010-09-30 |
$0.02B |
$0.41B |
4.60% |
| 2010-06-30 |
$-0.01B |
$0.39B |
-2.34% |
| 2010-03-31 |
$-0.01B |
$0.38B |
-2.60% |
| 2009-12-31 |
$-0.01B |
$0.38B |
-2.34% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$2.380B |
$1.221B |
|
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.
|
